CBL proteins and their domains
The c-Cbl protooncogenic protein was initially identi®ed as the cellular form of v-Cbl, a Gag-fusion transforming protein of Cas NS-1 retrovirus (Langdon et al., 1989a,b) . c-Cbl is a very large (906 and 913 amino acids in humans and mice, respectively), ubiquitously expressed, primarily cytoplasmic protein.
Following its identi®cation, two additional mammalian members of the Cbl family, Cbl-b and Cbl-3/Cbl-c (referred to as Cbl-3 elsewhere in the text), and their vertebrate and invertebrate homologues have been identi®ed (Adler et al., 2000; Hime et al., 1997; Keane et al., 1995 Keane et al., , 1999 Kim et al., 1999; Meisner et al., 1997; Robertson et al., 2000; Wang et al., 2000b; Yoon et al., 1995) . Based on the comparison of their structures, Cbl proteins can be divided into several distinct domains (Figure 1 ).
The highly conserved N-terminal domain of Cbl proteins includes the sequence homologous to v-Cbl, a zinc-binding RING ®nger and a short linker region between them. The v-Cbl homologous part encompasses a four-helix bundle (4H), a calcium-binding EFhand domain and a modi®ed SH2 domain (Meng et al., 1999) . This N-terminal domain of c-Cbl is capable of binding to phosphotyrosine residues of multiple protein tyrosine kinases (PTKs) and is, therefore, referred to as the tyrosine kinase binding (TKB) domain (Bonita et al., 1997; Lupher et al., 1996 Lupher et al., , 1997 . The RING ®nger is essential for the functions of Cbl proteins as E3-type ubiquitin-protein ligases (Joazeiro et al., 1999; Levkowitz et al., 1999; Waterman et al., 1999b) , most likely due to its ability to mediate binding of Cbl proteins to E2 ubiquitin-conjugating enzymes (Zheng et al., 2000) . Less is known about the linker sequence between the Cbl SH2-like domain and the RING ®nger, but it has been shown recently that this linker is crucial for E3 activity and transformation potential of c-Cbl (Thien et al., 2001) .
The conserved N-terminal sequences of Cbl proteins are typically followed by a proline-rich region, which appears to mediate binding of these proteins to SH3 domains (Cory et al., 1995; Donovan et al., 1994; Fukazawa et al., 1995; Keane et al., 1995; Rivero-Lezcano et al., 1994) . c-Cbl, Cbl-b and D-CblL have extensive proline-rich regions with a number of putative SH3-binding motifs (Keane et al., 1995; Langdon et al., 1989b; Robertson et al., 2000) , Sli-1 and Cbl-3 have very short proline-rich regions (Keane et al., 1999; Kim et al., 1999; Yoon et al., 1995) and the short D-Cbl form has none (Hime et al., 1997; Meisner et al., 1997) .
In addition to the proline-rich region, the C-terminal part of c-Cbl contains several tyrosine phosphorylation sites. Tyrosines 700, 731 and 774 have been identi®ed as major phosphorylation sites of c-Cbl by PTKs (Feshchenko et al., 1998) . Phosphotyrosine residues of c-Cbl mediate multiple c-Cbl interactions with SH2 domain-containing proteins.
The C-terminal-most fragments of c-Cbl, Cbl-b and the long form of Drosophila Cbl (D-CblL) contain a leucine zipper (Blake et al., 1991; Keane et al., 1995; Robertson et al., 2000) capable of mediating dimerization of Cbl proteins (Bartkiewicz et al., 1999) . These sequences also contain a homology to multiple enzymes involved in the ubiquitination pathway referred to as a UBA domain (Homan and Bucher, 1996) , which appears to be dispensable for Cbl-mediated ubiquitination (Levkowitz et al., 1999) .
Tissue expression of mammalian CBL proteins
c-Cbl is ubiquitously expressed in mammalian cells. The presence of c-Cbl mRNA has been shown in several tissues, including thymus, spleen, testis, lung, brain and heart, as well as in a wide variety of cell lines of hematopoietic origin (Langdon et al., 1989b) . Consistent with these results, c-Cbl protein has been found in cells of lymphoid lineage, including multiple T-cell lines (Blake and Langdon, 1992; Cory et al., 1995; Donovan et al., 1994; Hartley et al., 1995; Mushinski et al., 1994) , primary T cells (Marengere et al., 1997; Salojin et al., 1997) , numerous lines of Bcellular origin (Cory et al., 1995; Hartley et al., 1995; Okuda et al., 1996; Panchamoorthy et al., 1996; Smit et al., 1996b; Uddin et al., 1996) , primary B cells (Kim et al., 1995; Nishizumi et al., 1995) , and NK cells (Cerboni et al., 1998; Gesbert et al., 1998) . c-Cbl protein has also been found in various cells of myeloid lineage, including multiple myeloid progenitor cell lines (de Jong et al., 1995; Kanagasundaram et al., 1996; Marcilla et al., 1995; Oda et al., 1996; Odai et al., 1995; Okuda et al., 1996; Rivero-Lezcano et al., 1994; Wisniewski et al., 1996) , monocytic cell lines and primary macrophages (Erdreich-Epstein et al., 1997; Kanagasundaram et al., 1996; Matsuo et al., 1996b; Tanaka et al., 1995) , primary neutrophils (Brizzi et al., 1998; Naccache et al., 1997) , eosinophils (Kato et al., 1998) , mast cells Suzuki et al., 1997) , a megakaryoblastic cell line (Brizzi et al., 1996; Sasaki et al., 1995) and platelets (Oda et al., 1996) . c-Cbl protein is also present in osteoclasts and osteoblasts (Tanaka et al., 1996) , epithelial cells Mushinski et al., 1994) , ®broblasts (Galisteo et al., 1995; Tanaka et al., 1995) , adipocytes , smooth muscle cells (Lazaar et al., 2001 ) and cells of the neuroendocrine phenotype (Galisteo et al., 1995; Khwaja et al., 1996) . Expression levels of c-Cbl, both mRNA and protein, are higher in cells of hematopoietic origin than in non-hematopoietic ones (Langdon et al., 1989b; .
Similar to c-Cbl, Cbl-b is expressed ubiquitously. Its mRNA has been found in spleen, testis, ovary, placenta, heart, thymus, prostate, kidney, small intestine, colon, brain, lung, liver, skeletal muscle, pancreas, and salivary gland (Bustelo et al., 1997; Keane et al., 1995) . Spleen appears to have the highest level of Cbl-b mRNA among the tissues surveyed in these studies (Bustelo et al., 1997; Keane et al., 1995) . Cbl-b mRNA (Wang et al., 2000b) , Xenopus c-Cbl (Adler et al., 2000) , human Cbl-b (Keane et al., 1995) , the long splice form of human Cbl-3 (Keane et al., 1999; Kim et al., 1999) , D-CblL (the long splice form of Drosophila Cbl) (Robertson et al., 2000) , and Sli-1 from C. elegans (Yoon et al., 1995) . The number of amino acid residues in each sequence is shown at the right of the Figure. Only partial sequence is known for Xenopus c-Cbl, therefore the total number of amino acid residues for this protein is unknown. (The positioning of Xenopus c-Cbl relative to its human homolog is based on the overlap of their sequences within TKB, linker and RING domains.) The regions of human c-Cbl shown as TKB, linker+RING and C-terminal domain correspond to its amino acid residues 51 ± 351, 352 ± 420 and 421 ± 906, respectively. The fragment 857 ± 895 inside the C-terminal domain of c-Cbl is shown as LZ/UBA. Numbers above these regions in individual proteins indicate their homology to the corresponding regions of human c-Cbl (amino acid identity) as determined using DNASIS. (The homology levels for C-terminal regions are calculated including the LZ/UBA domain.) The homology levels less than 50% are not shown. Oncogenic 70Z deletion is shown in the human sequence by a triangle. The 14-3-3 protein-binding sequence is underlined. This sequence is substantially modi®ed in Cbl-b as compared to c-Cbl, making its functionality unclear. The C-terminal tyrosine phosphorylation sites of human c-Cbl and their homologs in c-Cbl from other species are denoted by the letter Y. The CrkL-binding sites of Cbl-b are shown as its putative tyrosine phosphorylation sites ; Cbl-b does not exhibit signi®cant homology with the sequences surrounding tyrosine residues phosphorylated in c-Cbl is also present in cell lines of epithelial and myeloid nature (Keane et al., 1995) . Cbl-b protein has been found in myelomonocytic, T-and B-cell lines Lavagna-Sevenier et al., 1998a; Widmann et al., 1998) , as well as in primary T lymphocytes Chiang et al., 2000) .
Unlike c-Cbl and Cbl-b, Cbl-3 is expressed primarily in the gastrointestinal system. Cbl-3 mRNA has been found in small intestine, colon, liver, pancreas, as well as in trachea, prostate and placenta, but not in many organs and tissues expressing c-Cbl and Cbl-b at high levels, including spleen, thymus, peripheral blood lymphocytes, lymph nodes or bone marrow (Keane et al., 1999; Kim et al., 1999) . Consistent with this tissue distribution, Cbl-3 mRNA is present in multiple cell lines derived from colon carcinoma, but is absent in monocytic, T-or B-cell lines (Kim et al., 1999) .
Phosphorylation of CBL proteins

Tyrosine phosphorylation of Cbl proteins
The ability of c-Cbl to become tyrosine phosphorylated at a very high level is one of the features de®ning its involvement in cell signaling. First of all, c-Cbl was found to be a good substrate for activated oncogenic forms of PTKs, such as Bcr ± Abl (Andoniou et al., 1994 (Andoniou et al., , 1996 de Jong et al., 1995) , v-Abl (Andoniou et al., 1994 (Andoniou et al., , 1996 , and v-Src (Andoniou et al., 1996; Tanaka et al., 1995) . Furthermore, c-Cbl was shown to become tyrosine phosphorylated in response to a wide variety of extracellular stimuli. The ®rst indication of that came from the experiments with CD3 ligation on the Jurkat T-cell line (Donovan et al., 1994) . The T-cell receptor/CD3 (TCR/CD3) ligation-induced tyrosine phosphorylation of c-Cbl in T-cell lines and primary T cells was con®rmed and investigated further in multiple studies (Buday et al., 1996; Donovan et al., 1996; Fournel et al., 1996; Fukazawa et al., 1995; Hartley et al., 1995; Liu et al., 1996; Marengere et al., 1997; Reedquist et al., 1996; Salojin et al., 1997; Sawasdikosol et al., 1996; Tsygankov et al., 1996) . Likewise, c-Cbl becomes intensely phosphorylated on tyrosine following ligation of B-cell receptor (BCR) (Cory et al., 1995; Kim et al., 1995) , as well as other multichain immune recognition receptors. Thus, engagement of various Fcg receptors has been shown to induce tyrosine phosphorylation of c-Cbl in the HL-60 promyelocytic cell line (Marcilla et al., 1995) , macrophages , myelomonocytic cell lines (Chu et al., 1998; Erdreich-Epstein et al., 1997; Izadi et al., 1998; Matsuo et al., 1996a) , NK cells (Cerboni et al., 1998) and neutrophils (Hazeki et al., 1999; Naccache et al., 1997) . Ligation of Fca receptors on interferon (IFN)-g-dierentiated U937 myelomonocytic cells also induces tyrosine phosphorylation of c-Cbl (Park et al., 1999) , as does the ligation of Fce receptors on RBL-2H3 mast cell line and cultured mast cells (Suzuki et al., 1997) .
Signaling through growth factor receptor PTKs also results in phosphorylation of c-Cbl. For instance, ligation of epidermal growth factor (EGF) receptor induces tyrosine phosphorylation of c-Cbl in epithelial cells , ®broblasts (Bowtell and Langdon, 1995; Galisteo et al., 1995; and adipocytes (Ribon and Saltiel, 1997) . Insulin receptor in adipocytes (Ribon and Saltiel, 1997) , the LTK kinase, a receptor of the insulin receptor superfamily, expressed as a chimera with the EGF receptor extracellular domain in Ba/F3 Blymphoid cells (Ueno et al., 1997) , nerve growth factor (NGF) and ®broblast growth factor (FGF) receptors in derivatives of PC-12, a cell line of the neuroendocrine phenotype (Galisteo et al., 1995) and the hepatocyte growth factor/scatter factor receptor c-Met in epithelial cells (Fixman et al., 1997; Fournier et al., 2000; GarciaGuzman et al., 2000; Lamorte et al., 2000) , all induce tyrosine phosphorylation of c-Cbl in response to their respective ligands. Likewise, tyrosine phosphorylation of c-Cbl is induced by a wide spectrum of hematopoietic growth factor receptors. It occurs in ®broblasts upon ligation of the platelet-derived growth factor (PDGF) receptor (Bonita et al., 1997; Galisteo et al., 1995) , in primary macrophages and macrophage cell lines in response to colony-stimulating factor-1 (CSF-1) (Kanagasundaram et al., 1996; Tanaka et al., 1995; Wang et al., 1996) , in megakaryoblastic cell lines following their treatment with stem cell factor (SCF), a c-Kit ligand (Brizzi et al., 1996; Sattler et al., 1997a; Wisniewski et al., 1996) , and in myeloid progenitor cell lines in response to the activation of FLT3, a PTK receptor for FL factor (Lavagna-Sevenier et al., 1998b; Tse et al., 2000) .
c-Cbl becomes tyrosine phosphorylated also in response to a wide variety of cytokines. Thrombopoietin (TPO) induces tyrosine phosphorylation of c-Cbl in megakaryoblastic cell lines and platelets (Brizzi et al., 1996; Oda et al., 1996; Sasaki et al., 1995) . Erythropoietin (EPO) induces c-Cbl tyrosine phosphorylation in the erythroleukemic cell line UT-7 (Hanazono et al., 1996; Odai et al., 1995) , the erythroid cell line HCD-57 , and EPO receptortransfected Ba/F3, DA-3 and 32D cell lines of lymphoid and myeloid lineages Chin et al., 1997) . Granulocyte-macrophage colonystimulating factor (GM ± CSF) also induces c-Cbl tyrosine phosphorylation in UT-7 cells (Hanazono et al., 1996; Odai et al., 1995) . In addition, GM ± CSF induces c-Cbl tyrosine phosphorylation in human neutrophils (Naccache et al., 1997) . Treatment with interleukin (IL)-3 induces tyrosine phosphorylation of c-Cbl in 32D promyelocytic cells Chin et al., 1997) and EPO-dependent transfectants of Ba/F3 and DA-3 cell lines . IL-2 induces c-Cbl tyrosine phosphorylation in IL-2-dependent T and NK cell lines (Gesbert et al., 1998) , as does IL-4 in IL-4 receptor-transfected Ba/F3 cells (Ueno et al., 1998) . Furthermore, c-Cbl becomes tyrosine phosphorylated also in response to IFN-a in U-266 myeloma and 293T embryonal epithelial cell lines (Uddin et al., 1996) and to IFN-g in NB-4 promyelocytic leukemia cells (Alsayed et al., 2000b) .
Several hormones have also been shown to induce tyrosine phosphorylation of c-Cbl. Prolactin induces tyrosine phosphorylation of c-Cbl in Nb2 T-lymphoma cells and 32D myeloid cells expressing prolactin receptor (Hunter et al., 1997) , as does angiotensin II in GN4 epithelial cells (Li et al., 1998) , and growth hormone in growth hormone receptor-expressing CHO epithelial cells (Li et al., 1998) . Likewise, tyrosine phosphorylation of c-Cbl is caused by UTP binding to P 2Y2 , a G-protein-coupled receptor of extracellular nucleotides (Solto, 1998) . It should be noted that tyrosine phosphorylation of c-Cbl in response to angiotensin II and UTP appears to be mediated by EGF receptor (Li et al., 1998; Solto, 1998) .
Integrins represent another group of surface receptors inducing tyrosine phosphorylation of c-Cbl as a result of their ligation. Thus, b 1 -integrin crosslinking on transformed and normal B cells (Manie et al., 1997) , b 1 -and b 2 -integrin crosslinking on the megakaryoblastic cell line MO7e (Manie et al., 1997; Sattler et al., 1997b) , and ®bronectin-induced b 1 -integrin ligation on NIH3T3 ®broblasts (Ojaniemi et al., 1998) and macrophages (Meng and Lowell, 1998) cause tyrosine phosphorylation of c-Cbl. Likewise, a IIb b 3 -integrin ligation on platelets (Saci et al., 2000) and a IIb b 3 -expressing CHO cells transfected with Syk or Syk and Vav (Miranti et al., 1998) induces c-Cbl tyrosine phosphorylation. Furthermore, c-Cbl becomes tyrosine-phosphorylated in response to ligation of a M b 2 integrin (CD11b/CD18) on human eosinophils (Kato et al., 1998) , a 4 b 1 integrin on the HL-60 promyelocytic cell line (Finkelstein and Shimizu, 2000) , a V b 3 integrin on osteoclasts and a V b 3 integrin-expressing HEK293 epithelial cells (Sanjay et al., 2001) . It should be noted that integrins are not the only cell adhesion receptors capable of mediating tyrosine phosphorylation of cCbl, since it is also caused by the engagement of the p62/GPVI collagen receptor on platelets (Polgar et al., 1997) and VCAM-1 on airway smooth muscle cells (Lazaar et al., 2001) .
Furthermore, c-Cbl becomes tyrosine phosphorylated in response to ligation of multiple cell surface receptors, such as Fas (Schlottmann et al., 1996) and CD2 (Lin et al., 2001; Umehara et al., 1998) in Jurkat T-cell line, CD5 in thymocytes (Dennehy et al., 1998) , CD19 in A20 and DT40 B-cell lines (Beitz et al., 1999) , CD28 in primary and Jurkat T cells (Slavik et al., 1999) , CD38 in immature B cells Kitanaka et al., 1996) , dierentiated myelomonocytic cell lines (Kontani et al., 1996; Matsuo et al., 1996b) and primary NK cells (Mallone et al., 2001) , CD43 in MO7e megakaryoblastic cells (Anzai et al., 1999) , and CD46 in primary T cells (Astier et al., 2000) .
In addition, tyrosine phosphorylation of c-Cbl is induced by extracellular stimuli that may not exert their eects through cell surface receptors. For example, treatment of HL-60 and NB-4 promyelocytic cells with all-trans-retinoic acid (Alsayed et al., 2000a) and treatment of THP-1 myelomonocytic cells with mercuric chloride (Howlett et al., 1999) induce c-Cbl tyrosine phosphorylation. Mercuric chloride most likely exerts its eect through the activation of Srcfamily PTKs, primarily Hck (Howlett et al., 1999) .
Finally, various cell lines derived from cancer and surgical specimens demonstrate constitutive tyrosine phosphorylation of c-Cbl (Kamei et al., 2000) . This increase appears to be somewhat speci®c to colon and renal cancer. Although mechanisms mediating this phenomenon remain unclear, this observation suggests that c-Cbl tyrosine phosphorylation may be important for tumorigenesis.
Although dephosphorylation of c-Cbl has not been studied in great detail, it has been shown that c-Cbl is constitutively associated with the protein tyrosine phosphatase Lyp (Cohen et al., 1999) . The expression pattern of Lyp is predominantly lymphoid, matching that of c-Cbl. Furthermore, overexpression of Lyp reduces tyrosine phosphorylation of c-Cbl (Cohen et al., 1999) . Therefore, Lyp may play a negative regulatory role in tyrosine phosphorylation of c-Cbl and in its association with SH2-containing proteins.
Less is known about Cbl-b tyrosine phosphorylation, but it is clear that Cbl-b becomes tyrosine phosphorylated in response to several stimuli. Tyrosine phosphorylation of Cbl-b is induced by TCR/CD3 ligation in primary T cells . Cbl-b is also tyrosine phosphorylated in response to IL-7 and FL, a growth factor of early hematopoietic cells, in JEA2 pro-B cell line, and in response to FL in THP-1 myelomonocytic cell line (Lavagna-Sevenier et al., 1998a) . Furthermore, engagement of EGF receptor has been shown to induce tyrosine phosphorylation of c-Cbl in 32D cells overexpressing EGF receptor (Ettenberg et al., 1999a) . It should be noted, however, that Cbl-b tyrosine phosphorylation has not been observed in ®broblasts expressing EGF or PDGF receptors upon their treatment with the corresponding growth factors (Bustelo et al., 1997) .
Identity of PTKs phosphorylating Cbl proteins and Cbl tyrosine phosphorylation sites
Tyrosine phosphorylation of c-Cbl appears to be mediated by several PTKs. It has been shown that cCbl is phosphorylated by and binds to multiple receptor PTKs, including receptors for EGF (Bowtell and Langdon, 1995; Fukazawa et al., 1996; Galisteo et al., 1995; Levkowitz et al., 1996; , PDGF (Bonita et al., 1997; Galisteo et al., 1995) , insulin (Ribon and Saltiel, 1997) , NGF and FGF (Galisteo et al., 1995) , the hepatocyte growth factor (Fixman et al., 1997) and CSF-1 (Kanagasundaram et al., 1996; Tanaka et al., 1995; Wang et al., 1996) .
The identity of PTKs phosphorylating c-Cbl is less clear when c-Cbl tyrosine phosphorylation is induced via receptors lacking intrinsic PTK activity, such as TCR/CD3, BCR, Fc and cytokine receptors. It has been shown that c-Cbl forms complexes with a number of Src-family PTKs, which are known to be involved in signaling through these receptors, such as Lyn, Fyn, Hck, Fgr (Deckert et al., 1998a; Dombrosky-Ferlan and Corey, 1997; Feshchenko et al., 1998; Fournel et al., 1996; Fukazawa et al., 1995; Howlett et al., 1999; Marcilla et al., 1995; Meng and Lowell, 1998; Panchamoorthy et al., 1996; Scholz et al., 2000; Tezuka et al., 1996; Tsygankov et al., 1996; Uddin et al., 1997) , albeit not with Lck (Feshchenko et al., 1998; Fournel et al., 1996) . Furthermore, co-expression of c-Cbl with Fyn, Src, and Yes, but not Lck, results in its phosphorylation on tyrosine residues (Feshchenko et al., 1998) .
Studies involving cells de®cient for individual PTKs have indicated that Fyn is essential for c-Cbl tyrosine phosphorylation in response to TCR/CD3 ligation (Tezuka et al., 1996) , Lyn is essential for c-Cbl tyrosine phosphorylation in response to the engagement of BCR (Tezuka et al., 1996) or granulocyte (G)-CSF in B cells expressing G-CSF receptor (Grishin et al., 2000) , and c-Src is essential for c-Cbl tyrosine phosphorylation in osteoclasts (Tanaka et al., 1996) . Consistent with these ®ndings, tyrosine phosphorylation of c-Cbl in response to integrin ligation is blocked in macrophages de®cient for Hck, Fgr, and Lyn (Meng and Lowell, 1998) . Furthermore, treatment of cells with speci®c chemical inhibitors of Src-family PTKs dramatically inhibits tyrosine phosphorylation of c-Cbl induced by Fcg (Howlett et al., 1999) and PDGF (Blake et al., 2000) receptors.
It has also been shown that c-Cbl binds to Syk and Zap in several cell types (Deckert et al., 1998a; FitzerAttas et al., 1997; Fournel et al., 1996; Latour et al., 1996; Lupher et al., 1996 Lupher et al., , 1998 Marcilla et al., 1995; Ota et al., 1996; Panchamoorthy et al., 1996; Tezuka et al., 1996) . The studies conducted with PTK-de®cient cell lines have indicated that c-Cbl tyrosine phosphorylation is not blocked in Syk-de®cient B-cell lines (Grishin et al., 2000; Tezuka et al., 1996) . However, coexpression of c-Cbl with Syk consistently results in the tyrosine phosphorylation of c-Cbl (Deckert et al., 1998a; Feshchenko et al., 1998; Latour et al., 1996) . Furthermore, ligation of an arti®cial chimeric receptor that includes Syk as its cytoplasmic domain induces tyrosine phosphorylation of c-Cbl (Fitzer-Attas et al., 1997). In contrast, Zap phosphorylates c-Cbl only when Fyn or Lck is also present (Feshchenko et al., 1998; Fournel et al., 1996) . Therefore, it appears that the major role in tyrosine phosphorylation of c-Cbl induced through receptors lacking intrinsic PTK activity is played by Src-family PTKs and Syk.
Consistent with the ®ndings demonstrating tyrosine phosphorylation of c-Cbl by multiple non-receptor PTKs, c-Cbl is also phosphorylated by and binds to activated oncogenic forms of Abl and Src (Andoniou et al., 1994 (Andoniou et al., , 1996 de Jong et al., 1995; Feshchenko et al., 1999; Tanaka et al., 1995) . c-Cbl has also been found in a complex with Tyk2 (Uddin et al., 1996) , but the role of this PTK in c-Cbl tyrosine phosphorylation remains to be elucidated. It is feasible that Jak-family PTKs, including Tyk2, are involved in the tyrosine phosphorylation of c-Cbl following ligation of cytokine receptors.
Tyrosines 700, 731 and 774 have been identi®ed as the major sites of c-Cbl tyrosine phosphorylation by non-receptor PTKs (Andoniou et al., 1996; Feshchenko et al., 1998) . It appears that all non-receptor PTKs phosphorylate c-Cbl at these sites, demonstrating no signi®cant individual speci®city (Andoniou et al., 1996; Feshchenko et al., 1998) . Phosphorylated tyrosines 700 and 774 have been shown to be binding sites for Crkfamily adapter proteins (Andoniou et al., 1996; Reedquist et al., 1996; Sawasdikosol et al., 1996) . In addition, phosphorylated tyrosine 700 is capable of binding to Vav (Marengere et al., 1997) . Phosphorylated tyrosine 731 has been shown to be a binding site for p85 subunit of phosphatidylinositol-3' (PI-3') kinase (Feshchenko et al., 1998; Liu et al., 1997a) . Therefore, phosphorylation of tyrosines 700, 731 and 774 is essential for the ability of c-Cbl to interact with several crucial signaling proteins.
Since tyrosine phosphorylation of the c-Cbl mutant lacking tyrosines 700, 731 and 774 does not exceed 5% of that of wild-type c-Cbl (Feshchenko et al., 1998) , other tyrosines in c-Cbl appear to be phosphorylated at a relatively low stoichiometry. However, this fact does not rule out possible functional importance of lowstoichiometry tyrosine phosphorylation of c-Cbl.
Like c-Cbl, Cbl-b is tyrosine phosphorylated by multiple non-receptor PTKs when co-expressed with them in COS cells. Syk shows the highest level of Cbl-b tyrosine phosphorylation in this system. Furthermore, Syk has been shown to bind to and phosphorylate Cblb in Jurkat T-cell line . Tyrosine phosphorylation sites of Cbl-b have not been identi®ed yet. However, tyrosine residues 665 and 709 of Cbl-b have been determined as its CrkL-binding sites and, therefore, are likely to be phosphorylated.
Serine/threonine phosphorylation of Cbl proteins
In addition to inducing tyrosine phosphorylation of cCbl, TCR/CD3 ligation appears to increase its serine/ threonine phosphorylation, which facilitates binding of c-Cbl to 14-3-3 proteins (Liu et al., 1996 (Liu et al., , 1997b . Likewise, ligation of CD43 on T cells (Pedraza-Alva et al., 2001 ) and treatment of T cells with phorbol 12-myristate 13-acetate (PMA), a potent stimulator of protein kinase C (PKC) (Liu et al., 1997b) , appear to facilitate serine/threonine phosphorylation of c-Cbl. Serine residues 619, 623, 639 and 642 of c-Cbl have been shown to be essential for its binding to 14-3-3 proteins (Pedraza-Alva et al., 2001) , which is likely to be important for c-Cbl functions, because 14-3-3 proteins are critically involved in numerous biological phenomena (Baldin, 2000; Muslin and Xing, 2000) .
In addition to increasing binding of c-Cbl to 14-3-3 proteins, serine/threonine phosphorylation of c-Cbl appears to attenuate its tyrosine phosphorylation. Treatment of T cells with PMA reduces tyrosine phosphorylation of c-Cbl in response to TCR/CD3 crosslinking and its binding to CrkL and p85 (Fernandez et al., 1999a; Liu et al., 1999) . Treatment of cells with a speci®c inhibitor of PKC blocks the observed eects of PMA on tyrosine phosphorylation of c-Cbl and its binding to CrkL and p85 and increases tyrosine phosphorylation of c-Cbl in response to CD3/ CD4-co-crosslinking (Fernandez et al., 1999a; . Furthermore, treatment of Fcg receptoractivated neutrophils with PMA decreases the amount of PTK activity co-immunoprecipitating with c-Cbl (Hazeki et al., 1999) . Likewise, treatment of neutrophils with inhibitors of serine/threonine phosphatases reduces tyrosine phopshorylation of c-Cbl in response to Fcg receptor ligation (Rollet-Labelle et al., 2000) . Consistent with these results, inhibition of PKC activity is required for EGF receptor-mediated tyrosine phosphorylation of c-Cbl in response to angiotensin II in GN4 epithelial cells (Li et al., 1998) .
Functions of CBL proteins
To date, c-Cbl has been found to play several roles, acting as a multifunctional regulator of cellular signaling. First, c-Cbl is thought to be a multivalent adapter protein. Second, c-Cbl is believed to be an inhibitor of multiple PTKs. Third, c-Cbl has been shown to act as an E3 ubiquitin-protein ligase. Experimental evidence for these functions, interrelations between them, their biological signi®cance, as well as functional dierences between c-Cbl and other Cbl-family proteins are addressed in this review, with the main accent placed on the adapter functions of Cbl proteins.
c-Cbl as a multivalent adapter protein
Binding of c-Cbl to multiple proteins involved in cellular regulation c-Cbl has been shown to form complexes with over 40 proteins via its various functional domains (Table 1 ). The TKB domain of c-Cbl binds to several receptor PTKs, Syk, Zap and Src. The RING ®nger recruits E2 ubiquitin-conjugating enzymes, notably UbcH7. The proline-rich region of c-Cbl mediates its interactions with a wide spectrum of SH3-containing proteins, such as Grb2, Nck, and Crk-family adapter proteins, p85, and Src-family PTKs. The C-terminal phosphorylated tyrosine residues of c-Cbl provide docking sites for several SH2-containing proteins, including p85, Crk-family adapters, and Src-family PTKs.
In addition to its ability to bind to other proteins, cCbl binds to itself via the C-terminal leucine zipper motif, thus forming dimers (Bartkiewicz et al., 1999) . Formation of c-Cbl dimers appears to play a physiological role, since deletion of the leucine zipper reduces tyrosine phosphorylation of c-Cbl and its association with EGF receptor (Bartkiewicz et al., 1999) . The formation of c-Cbl dimers can also increase a variety of proteins that are simultaneously recruited to c-Cbl.
Signaling pathways mediated by c-Cbl Findings demonstrating tyrosine phosphorylation of c-Cbl in response to various types of cell stimulation and interactions of c-Cbl with numerous proteins, that are known to be critically involved in signal transduction, have suggested that c-Cbl is a multivalent adapter protein. This view is supported by a number of functional studies. First of all, tyrosine phosphorylation of c-Cbl by c-Src appears to be essential for bone resorption, since c-Cbl is tyrosine-phosphorylated in a Src-dependent manner in osteoclasts, and bone resorption by osteoclast-like cells in vitro is inhibited by both c-Src-and c-Cbl-speci®c antisense oligonucleotides (Tanaka et al., 1996) . Although these results do not elucidate the mechanism by which c-Cbl acts downstream of c-Src in a signaling pathway that is required for bone resorption, it is feasible that binding of c-Cbl to p85 plays a role in the observed eects of c-Cbl (Lakkakorpi et al., 1997) .
Likewise, tyrosine phosphorylation-dependent binding of c-Cbl to the p85 subunit of PI-3' kinase appears to be essential for B-cell proliferation and survival in response to IL-4 (Ueno et al., 1998) . This study has demonstrated that c-Cbl is phosphorylated on tyrosine and associated with p85 in response to IL-4 stimulation. Furthermore, overexpression of c-Cbl enhances the PI-3' kinase activity, as well as cell proliferation and survival, in the presence of IL-4. These eects of cCbl are abolished by wortmannin, a speci®c inhibitor of PI-3' kinase, or by a mutation at tyrosine 731, the major c-Cbl binding site for p85. A similar phenomenon has been demonstrated for G-CSF stimulation of the B-cell line DT40 (Grishin et al., 2000) . G-CSF induces tyrosine phosphorylation of c-Cbl and increases activity of PI-3' kinase in DT40 cells, whereas both inhibition of PI-3' kinase by wortmannin and expression of the Y731F c-Cbl mutant decreases G-CSF-induced DNA synthesis in this system (Grishin et al., 2000) .
Furthermore, binding of c-Cbl to PI-3' kinase through the phosphorylated tyrosine 731 of c-Cbl appears to play a critical role in the activation of Erk2 kinase (Finkelstein and Shimizu, 2000) . The expression of wild-type c-Cbl enhances basal Erk2 activity in the HL-60 promyelocytic cells with a minimal eect on a 4 b 1 integrin-mediated Erk2 activity. In contrast, overexpression of the HUT-Cbl truncation mutant, which lacks the C-terminal domain and, hence, does not associate with p85, has no eect on Erk2 activity. These results therefore suggest that c-Cbl has a role in basal, but not integrin-mediated, activation of Erk2.
c-Cbl also becomes tyrosine-phosphorylated in response to the engagement of c-Met hepatocyte growth factor receptor in HeLa cells or following expression of the oncogenic Trp-Met form of this receptor (Garcia-Guzman et al., 2000) . Met-induced tyrosine phosphorylation of c-Cbl renders it capable of binding various SH2-containing proteins, including cCrk-I and c-Crk-II. This study further indicates that binding of tyrosine-phosphorylated c-Cbl to c-Crk is crucial for Met-induced activation of Jnk in HeLa cells. Interestingly, c-Cbl also facilitates Met-induced activation of Erk in these cells, but this eect of c-Cbl is Crk-independent (Garcia- Guzman et al., 2000) .
In addition to providing a link between c-Cbl tyrosine phosphorylation and Jnk activation, Crk proteins appear to mediate other functions of c-Cbl, as well. Binding of c-Cbl to Crk proteins has been shown to be mediated primarily by interactions between phosphorylated tyrosines of c-Cbl and Crk SH2 (Buday et al., 1996; de Jong et al., 1995; Khwaja et al., 1996; Reedquist et al., 1996; Ribon et al., 1996; Salgia et al., 1996a; Sattler et al., 1996; Sawasdikosol et al., 1996; Smit et al., 1996a,b) . More speci®cally, CrkL, which demonstrates the highest level of binding to cCbl among mammalian Crk proteins Uemura et al., 1997; van Leeuwen et al., 1999b) , binds to phosphotyrosines 700 and 774 of c-Cbl (Andoniou et al., 1996; Feshchenko et al., 1999) . Interactions between c-Cbl and Crk proteins are likely to be important, since Crk proteins form complexes with C3G, a speci®c GTP/GDP-exchange factor for Rap 1, a Ras-like small GTPase (Gotoh et al., 1995; Ichiba et al., 1997; Ingham et al., 1996; Sawasdikosol et al., 1995; Smit et al., 1996b) , and are involved in Rap 1 activation (Gotoh et al., 1995; Ichiba et al., 1997) . The presence of both CrkL and C3G in c-Cbl immune complexes has indeed been shown . Consistent with these ®ndings, stimulation of NB-4 promyelocytic cells by IFN-g causes tyrosine phosphorylation and association of c-Cbl and CrkL followed by activation of Rap 1 (Alsayed et al., 2000b) . All these ®ndings argue in favor of the notion that cCbl may play a crucial role in the c-Cbl/Crk(L)/C3G pathway leading to Rap 1 activation.
Several studies have been carried out attempting to link c-Cbl tyrosine phosphorylation to Rap 1 activation. First, tyrosine phosphorylation of c-Cbl and its association with CrkL have been shown to correlate with an increase in Rap 1 activity in anergic T cells (Boussiotis et al., 1997) . This study implicates the cCbl/Crk(L)/C3G pathway in mediating T-cell anergy. These results are consistent with the observation that cCbl is hyperphosphorylated on tyrosine residues in nonobese diabetic (NOD) mouse thymocytes, which are known to be hyporesponsive to antigens (Salojin et al., 1997) . These studies are in agreement with the view of Rap 1 as a negative regulator of Ras-dependent processes (Kawata et al., 1988; Kitayama et al., 1989) . However, recent advances indicate that, in addition to the suppression of Ras signaling in certain systems, Rap 1 acts as a positive regulator of multiple processes, including Erk activation (York et al., 1998) , cell proliferation and transformation (Altschuler and Ribeiro-Neto, 1998; Yoshida et al., 1992) , morphogenesis (Asha et al., 1999) , and, possibly, positive selection of thymocytes (Amsen et al., 2000) .
SH3-dependent interactions between c-Cbl and Nck have been shown in several systems (Izadi et al., 1998; Rivero-Lezcano et al., 1994; Wunderlich et al., 1999) . These interactions appear to have important biological consequences, since co-expression of c-Abl, c-Cbl and Nck K229, a mutant form of Nck lacking functionality of its third SH3 domain, causes severe defects in the patterning of Xenopus embryos (Adler et al., 2000) . The physiological role of these interactions and the mechanisms, by which they aect embryonal development, remain to be understood.
c-Cbl also binds to Grb2, an adapter protein involved in various signaling pathways, including activation of Ras by PTKs. This SH3-dependent binding has been demonstrated in numerous experimental systems (see Table 1 ). Some studies indicate that binding of c-Cbl to Grb2 may be reduced by extracellular cell stimulation . In spite of the importance of Grb2 for cell signaling, the functional signi®cance of the association between c-Cbl and Grb2 is not suciently understood.
CAP, an SH3-containing adapter protein, binds to cCbl and recruits it to the insulin receptor in adipocytes (Ribon et al., 1998b) . Upon insulin stimulation, c-Cbl becomes tyrosine phosphorylated (Ribon and Saltiel, 1997) , and its complex with CAP dissociates from the receptor and moves to the detergent-resistant membrane fraction, where it binds to¯otillin (Baumann et al., 2000) . Tyrosine-phosphorylated c-Cbl then recruits the c-CrkII-C3G complex from the cytosol, thus activating the small GTPase TC10. This c-Cblmediated activation of TC10 is essential for translocation of the glucose transporter protein GLUT4 to the cell surface, which mediates the eect of insulin on glucose uptake (Chiang et al., 2001 ).
Eects of c-Cbl on cell adhesion and cytoskeletal rearrangements Among all the studies directed at unraveling functions of c-Cbl as an adapter protein, those addressing its role in cell adhesion and cytoskeleton-related events represent a very substantial fraction. Several lines of experimentation indicate that c-Cbl binding to PI-3' kinase and to Crk proteins is not only involved in the proliferative and metabolic responses that have been discussed above, but also in the eects of c-Cbl on cell adhesion and cytoskeletal rearrangements.
Rap 1 activity in NIH3T3 ®broblasts has been shown to be increased by their adhesion (Posern et al., 1998) . Furthermore, Rap 1 activity has been shown to facilitate adhesion and spreading of hematopoietic cells (Katagiri et al., 2000; Reedquist et al., 2000; Tsukamoto et al., 1999) . These ®ndings argue that cCbl/Crk(L)/C3G/Rap 1 signaling is involved in regulation of cytoskeleton-mediated processes. Several other studies further argue in favor of this point of view. Thus, overexpression of CrkL in hematopoietic cell lines increases their adhesion to and migration through extracellular matrix (ECM) in a manner dependent on the intact structure of both SH3 and SH2 domains of CrkL (Senechal et al., 1998; Uemura and Grin, 1999) . The major CrkL SH3-and SH2-binding proteins have been identi®ed as C3G and c-Cbl, respectively (Uemura and Grin, 1999) . Furthermore, it has been shown that overexpression of wild-type c-Cbl, but not Proteins associated with phosphoserine residues of c-Cbl 14-3-3t, z Fifteen C-terminal T cells GST pull-down assay, Enhanced by (Liu et al., 1996 (Liu et al., , 1997b (Feshchenko et al., 1999; Teckchandani et al., 2001) . These eects of c-Cbl appear to be caused by upregulation of cytoskeletal rearrangements by cCbl-mediated activation of small GTPases, possibly including Rap 1 (Teckchandani et al., 2001) . R-Ras is another small GTPase that has been shown to increase ligand-binding activity of integrins, converting suspension cells into adherent ones (Osada et al., 1999; Wang et al., 2000a; Zhang et al., 1996) . Although no evidence has been presented for the involvement of R-Ras in mediating positive eects of cCbl on cell adhesion and spreading, CrkL appears to be involved in the activation not only of Rap 1, as discussed above, but also of R-Ras (Arai et al., 1999; Gotoh et al., 1997) . Therefore, R-Ras may represent a possible eector of c-Cbl in cell adhesion-related processes.
The eects of c-Cbl on cytoskeletal processes are likely to be dependent on its interactions with proteins other than Crk. Binding of c-Cbl to the p85 subunit of PI-3' kinase, which is discussed above as a critical event of Erk activation and proliferative responses, is also essential for the observed eects of c-Cbl on cell adhesion and morphology. c-Cbl-mediated adhesion and spreading of v-Abl-transformed NIH3T3 ®bro-blasts, as well as deposition of ECM by these cells, are abrogated by Y731F mutation of c-Cbl, which prevents binding of p85 to c-Cbl; by wortmannin treatment, which inhibits the enzymatic activity of PI-3' kinase; or by overexpression of a dominant-inhibitory p85 mutant, which blocks binding of the endogenous PI-3' kinase to c-Cbl (Feshchenko et al., 1999; Teckchandani et al., 2001) . The observed dependence of the eects of c-Cbl on cell adhesion and morphology from its binding to PI-3' kinase is likely to be due to a crucial role of PI-3' kinase in the activation of Rhofamily GTPases (Nobes et al., 1995; Parker, 1995; Reif et al., 1996) . Indeed, activation of Rac 1 has been shown in v-Abl-transformed NIH3T3 cells overexpressing wild-type c-Cbl, but not its mutants defective for p85 binding (Teckchandani et al., 2001) . Finally, inhibition of Rho-and Rac 1-mediated signaling abrogates the eects of c-Cbl in v-Abl-transformed NIH3T3 cells (Teckchandani et al., 2001) . The notion that small GTPases may be downstream eectors of cCbl is further supported by the study in adipocytes demonstrating that recruitment of the c-CrkII-C3G complex to tyrosine-phosphorylated c-Cbl in lipid rafts activates the small GTPase TC10 (Chiang et al., 2001) .
In addition to binding to p85 and Crk proteins, cCbl also interacts with several other proteins known to be involved in cell adhesion and cytoskeletal rearrangements. Thus, c-Cbl has been shown to bind to the focal adhesion proteins paxillin and talin (Salgia et al., 1996b) . c-Cbl also binds, in an SH3-dependent fashion, to CAP protein (Ribon et al., 1998a) , which interacts with Fak, co-localizes with actin stress ®bers and induces the formation of actin stress ®bers and focal adhesions in NIH3T3 cells (Ribon et al., 1998b) . Furthermore, c-Cbl has been shown to bind to CMS/ CD2AP protein, an adapter-type molecule thought to be involved in the regulation of actin cytoskeleton (Kirsch et al., 2001 ). This study indicates that c-Cbl binding to CMS/CD2AP depends on both proline-rich motifs and phosphorylated tyrosine residues in the Cterminal domain of c-Cbl. CMS/CD2AP and c-Cbl have been found co-localized with F-actin in mem- In contrast to other TKB-dependent interactions, this interaction is neither tyrosine phosphorylation-dependent nor sensitive to the G306E mutation of c-Cbl.
c The binding site of c-Cbl for CD2AP/CMS has been mapped to the region between the amino acid position 648 and the C-terminus of c-Cbl and is dierent from the proline-rich motifs binding to SH3-containing proteins. d A truncated form of c-Cbl lacking proline-rich motifs fails to form a complex with Syk . However, Syk possesses no SH3 domains. Therefore, this interaction is likely to be indirect. e c-Cbl has been shown to be incapable of binding to individual SH2 and SH3 domains of Hck, whereas capable of binding to full-length Hck . (Feshchenko et al., 1998; Fournel et al., 1996; Fukazawa et al., 1995; Tsygankov et al., 1996) . (Kirsch et al., 2001 ). It has also been shown that c-Cbl is targeted to ®broblast actin lamellae, where it co-localizes with Crk . This study demonstrates that lamellipodia formation and actin targeting of c-Cbl is disrupted by the expression of c-Cbl mutant forms incapable of binding to SH3 domains. Therefore, this function of c-Cbl appears to require an interaction between the proline-rich motifs of c-Cbl and an actinassociated SH3-containing protein . One may speculate that CMS and CAP are likely candidates for this function.
In addition to binding to multiple components of focal adhesions and actin cytoskeleton, c-Cbl, along with Vav and Syk, is capable of constitutively binding to tubulin, the major component of microtubuli (Fernandez et al., 1999b) . Interestingly, it has been found recently that c-Cbl constitutively binds, via its RING ®nger, to Sprouty2 protein. The latter colocalizes with microtubuli and membrane rues in quiescent and EGF-stimulated COS cells, respectively (Wong et al., 2001) . Therefore, Sprouty2 appears to be a sound candidate for targeting c-Cbl to both microtubuli and actin cytoskeleton.
The role of c-Cbl in regulating cell adhesion and cytoskeletal rearrangements is further supported by numerous ®ndings indicating its downstream role in cell signaling triggered by adhesion receptors. Thus, tyrosine phosphorylation of c-Cbl has been shown in multiple cell types in response to engagement of b 1 integrins (Manie et al., 1997; Meng and Lowell, 1998; Sattler et al., 1997b) (Miranti et al., 1998; Saci et al., 2000) , and VCAM (Lazaar et al., 2001) . Upon ligation of adhesion receptors, c-Cbl becomes tyrosine-phosphorylated and forms complexes with several proteins involved in signaling pathways regulating cell adhesion and cytoskeletal phenomena, such as PI-3' kinase (Miranti et al., 1998; Ojaniemi et al., 1997; Saci et al., 2000) , CrkL (Sattler et al., 1997b) , Src (Ojaniemi et al., 1997; Sanjay et al., 2001) , and Syk (Saci et al., 2000) . Therefore, c-Cbl is likely to be involved in thè outside-in' signaling by integrins and other adhesion receptors.
It is unclear whether or not c-Cbl physically interacts with integrin subunits. However, its ability to bind to 14-3-3 proteins (Liu et al., 1996 (Liu et al., , 1997b Pedraza-Alva et al., 2001 ) may provide a mechanism for such binding, since the b 1 integrin cytoplasmic domain has been shown to interact with 14-3-3b protein in vivo and in vitro (Han et al., 2001) . Furthermore, overexpression of 14-3-3b facilitates spreading and migration of NIH3T3 ®broblasts on ECM, thus supporting the notion of the importance of 14-3-3 proteins in integrinmediated processes (Han et al., 2001) .
Furthermore, the adapter function of c-Cbl may also be crucial for`inside-out' integrin signaling. Thus, tyrosine phosphorylation of c-Cbl and activation of PI-3' kinase associated with c-Cbl are essential for CD28-triggered upregulation of b 1 integrin on T cells (Zell et al., 1998) . Likewise, tyrosine phosphorylation of c-Cbl and its binding to PI-3' kinase appear to be essential for LPS-induced upregulation of macrophage adhesion (Scholz et al., 2000) .
Another functional evidence of the essential role of c-Cbl in cell adhesion is provided by blocking of macrophage spreading on ®bronectin surfaces following treatment of these cells with c-cbl-speci®c antisense oligonucleotides (Meng and Lowell, 1998) . In agreement with the reports discussed above, this study indicates that the c-Cbl-dependent adhesion and spreading of macrophages is dependent on the activity of Src-family PTKs and PI-3' kinase.
Finally, it should be noted that cell adhesion-and cytoskeleton reorganization-related phenomena induced by c-Cbl in certain experimental systems may be unrelated to its adapter functions, but be related instead to its ability to inhibit PTK-mediated signaling. For example, c-Cbl appears to inhibit adhesion of the epithelial cell line 293-VnR, which expresses the a v b 3 vitronectin receptor, to vitronectin by virtue of its ability to inhibit c-Src in a TKB-dependent manner (Sanjay et al., 2001) . Furthermore, another study has indicated that mutant forms of c-Cbl, which are capable of blocking the inhibition of PTK-mediated signaling by c-Cbl, induce epithelial-mesenchymal transition of epithelial cells (Fournier et al., 2000) . The epithelial-mesenchymal transition caused by c-Cbl mutant forms is unrelated to the C-terminal domain of c-Cbl, while related to the ability of c-Cbl to bind to PTKs via its TKB domain (Fournier et al., 2000) , thus arguing that this eect is dependent on the c-Cblmediated inhibition of PTK signaling. (The inhibitory potential of c-Cbl and molecular mechanisms underlying it are discussed in detail below.) Possible adapter functions of Cbl-b It remains to be elucidated whether Cbl-b functions as an adapter protein. However, considering that Cbl-b has been shown to bind to a variety of signaling proteins, including EGF receptor (Keane et al., 1995) , Vav Bustelo et al., 1997) , Zap Zhang et al., 1999b) , Syk , Grb2 Ettenberg et al., 1999a) , CrkL , p85 Fang et al., 2001) , Lck , PLC-g and Slp-76 , it is likely that Cbl-b, like c-Cbl, acts as an adapter. Furthermore, TKB-dependent interaction of Cbl-b with Zap in T cells has been shown to constitutively activate NF-AT (Zhang et al., 1999b) . This positive role of Cbl-b in T-cell signaling based on its interaction with Zap additionally argues in favor of the notion that Cbl-b acts as an adapter protein.
Does recruitment of proteins to c-Cbl involve their translocation between subcellular compartments?
The adapter eects of c-Cbl, like biological eects of other adapter molecules, are based on its binding to various signaling proteins resulting in the formation of multiprotein complexes. In many cases, functioning of adapter proteins involves translocation of their complexes with other proteins between subcellular compartments. It appears likely that such translocation is also important for c-Cbl.
Several studies indicate that tyrosine phosphorylation of c-Cbl may result in its redistribution to the membrane and the cytoskeleton. First, stimulation of platelets with thrombin induces translocation of a substantial fraction of c-Cbl to the Triton X-100-insoluble fraction, presumably cytoskeleton, thus suggesting a role for c-Cbl in platelet aggregation (Oda et al., 1996) . Tyrosine phosphorylation-dependent translocation of c-Cbl to the detergent-insoluble fraction has also been observed in T-cell lines stimulated by CD3 ligation (Hartley and Corvera, 1996) . Furthermore, c-Cbl has been found to be constitutively tyrosine-phosphorylated and present in the detergent-resistant particulate fractions of blast cells from acute leukemia patients and polymorphonuclear neutrophils from chronic myelogenous leukemia patients (Brizzi et al., 1998) . c-Cbl localization in these transformed cells diers dramatically from its cytosolic localization in their normal counterparts. This study also shows that translocation of c-Cbl to the detergentresistant fraction can be induced by extracellular stimulation of MO7e megakaryoblastic cells. Furthermore, it demonstrates that cell transformation causes translocation of c-Cbl not only to the detergentresistant, presumably cytoskeletal fraction, but also to the detergent-soluble membrane fraction (Brizzi et al., 1998) . Membrane translocation of c-Cbl has also been shown in macrophages stimulated through the CSF-1 receptor and integrins (Ojaniemi et al., 1997) . In both cases, c-Cbl was present in the membrane as a complex with Shc, Grb2 and p85 or p85 and c-Src (Ojaniemi et al., 1997) . Membrane translocation of tyrosine-phosphorylated c-Cbl has also been shown in T-cell lines following CD3 crosslinking (Hartley and Corvera, 1996) . In addition, this study indicates that p85 in T cells binds to the membrane-associated form of c-Cbl to a much higher extent than to the cytosolic one.
Localization of c-Cbl to speci®c membrane structures has not been mapped in detail, but it appears that c-Cbl can be translocated to both plasma and intracellular membranes Wang et al., 1999) . Recent studies have revealed that a substantial fraction of membrane-associated c-Cbl is localized to rafts, cholesterol-enriched detergent-resistant membrane patches (Baumann et al., 2000; Lafont and Simons, 2001) . This membrane fraction is rich in a number of critical signaling molecules and may act as a hub of signaling activity on the cell membrane (Janes et al., 2000) . Therefore, localization of c-Cbl to the lipid rafts may be extremely important for its functions as an adapter protein.
Cbl proteins as ubiquitin-protein ligases Ubiquitination is a post-translation protein modi®cation that requires ATP and three dierent enzymes, a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3). In short, free ubiquitin is recruited to E1 by thioester bond formation and then transferred to E2 through another thioester bond formed between E2 and ubiquitin. E2, in conjunction with E3, transfers ubiquitin to a target protein. There are two major families of E3, which possess either a domain homologous to E6-AP C-terminus (HECT) or a RING ®nger motif. Ubiquitination is involved in a multitude of cellular processes, including cell cycle control, endocytosis, signal transduction, DNA repair, and apoptosis Hicke, 2001; Hochstrasser, 2000; Kornitzer and Ciechanover, 2000; Weissman, 2001) .
Ubiquitination has recently emerged as a crucial function of Cbl-family proteins. A number of studies have demonstrated that c-Cbl promotes ligand-induced ubiquitination of EGF receptor (Levkowitz et al., 1998) , PDGF receptors a and b (Miyake et al., , 1999 , and CSF-1 receptor (Lee et al., 1999; , thus targeting these activated receptor PTKs for proteosomal degradation. The explanation for these desensitizing eects of c-Cbl has been given by the discovery of the E3 ubiquitin-protein ligase activity of c-Cbl. As an E3 ubiquitin-protein ligase, c-Cbl recognizes tyrosine-phosphorylated substrates and then recruits E2 ubiquitin-conjugating enzymes through its RING domain (Joazeiro et al., 1999; Levkowitz et al., 1999; Waterman et al., 1999a) . The E3 activity of c-Cbl is strictly dependent on the presence of an intact RING ®nger, since mutations within this domain, notably C381A, completely abrogate c-Cbl-mediated ubiquitination (Joazeiro et al., 1999; Waterman et al., 1999b) . Several E2 enzymes have been shown to support cCbl-mediated ubiquitination of receptor PTKs in vitro. Thus, Ubc4 supports c-Cbl-mediated ubiquitination of PDGF receptor (Joazeiro et al., 1999) , whereas UbcH5B/C and UbcH7 support c-Cbl-mediated ubiquitination of EGF receptor (Levkowitz et al., 1999; Yokouchi et al., 1999a) . The structure of the complex between the UbcH7 E2 ubiquitin-conjugating enzyme, the c-Cbl fragment encompassing its TKB and RING domains, and a phosphotyrosine-containing PTK peptide has been determined identifying multiple contacts of the RING ®nger and the adjacent fragments of c-Cbl with the UbcH7 enzyme (Zheng et al., 2000) .
This and other studies indicate that TKB-mediated interactions between c-Cbl and PTKs are essential for c-Cbl-dependent ubiquitination of PTKs. It has been shown that the N-terminal fragment of c-Cbl lacking all its C-terminal sequences beginning with the RING ®nger is capable of binding to Syk, Zap, EGF and PDGF receptors (Bonita et al., 1997; Deckert et al., 1998a; Lupher et al., 1996 Lupher et al., , 1997 Lupher et al., , 1998 Thien and Langdon, 1997) . This binding is dependent on the intact structure of the c-Cbl SH2-like domain (Meng et al., 1999) , since the G306E mutation, corresponding to a loss-of-function mutation in Sli-1 Yoon et al., 1995) , abolishes c-Cbl TKB binding to PTKs (Bonita et al., 1997; Lupher et al., 1996 Lupher et al., , 1997 Lupher et al., , 1998 Thien and Langdon, 1997) . Although binding of full-length c-Cbl to EGF and PDGF receptors is not completely disrupted by the G306E mutation, probably, due to the substantial contribution of the Cterminal portion of c-Cbl to this binding, which may be mediated by Grb2 and other proteins associating with both c-Cbl and receptor PTKs, the G306E mutation substantially reduces this binding (Miyake et al., 1999; Thien and Langdon, 1997) . A decrease in binding between c-Cbl and receptor PTKs caused by inactivation of the SH2-like domain signi®cantly inhibits tyrosine phosphorylation of c-Cbl (Miyake et al., 1999; Thien and Langdon, 1997) and abrogates cCbl-induced ubiquitination of these PTKs Miyake et al., 1999) . Finally, the fragment of cCbl encompassing the TKB and RING domains is sucient for ubiquitination-mediated desensitization of EGF receptor (Levkowitz et al., 1999; Lill et al., 2000) .
These studies have therefore demonstrated that the C-terminal sites of tyrosine phosphorylation of c-Cbl are not essential for ubiquitination of EGF receptor. In contrast, Y371A mutation of c-Cbl, which involves tyrosine 371 adjacent to the RING ®nger, abrogates c-Cbl-mediated ubiquitination and subsequent degradation of EGF receptor, thus suggesting that phosphorylation of tyrosine 371 is required for E3 activity of c-Cbl (Levkowitz et al., 1999) . However, the crystal structure of UbcH7/c-Cbl/phospho-Zap complex shows that this tyrosine plays a structural role, thus providing an alternative explanation for the detrimental eect of Y371A mutation on E3 activity of c-Cbl (Zheng et al., 2000) .
EGF, PDGF and CSF-1 receptors are not the only proteins that are ubiquitinated by c-Cbl. It has been shown that recruitment of c-Cbl to the insulin receptor through the adapter protein APS results in rapid ubiquitination of this receptor (Ahmed et al., 2000) . Furthermore, c-Cbl has been shown to decrease the level of Syk protein in a RING-dependent fashion when c-Cbl and Syk are co-expressed in COS-7 cells Ota et al., 2000) . Similarly, degradation of activated Fyn and, consequently, inhibition of its kinase activity are caused by coexpression of Fyn with c-Cbl in 293T and Jurkat cells . Furthermore, receptors without intrinsic PTK activity may also be targets of c-Cblmediated ubiquitination. Thus, c-Cbl has been shown to ubiquitinate the TCR/CD3-z chain upon TCR/CD3 ligation in Jurkat T cells . Binding of c-Cbl to Zap and of Zap to the z chain is essential for this phenomenon, as are the RING ®nger and linker domains of c-Cbl . Likewise, Fce receptor appears to be a target of c-Cbl-mediated ubiquitination upon its engagement in RBL-2H3 basophilic cells (Lafont and Simons, 2001) .
Mammalian Cbl proteins other than c-Cbl are also capable of ubiquitinating activated PTKs. Cbl-b has been shown to ubiquitinate and downregulate EGF receptor and signaling mediated by it in a RINGdependent manner (Ettenberg et al., 1999a,b; Levkowitz et al., 1999) . Furthermore, Cbl-b induces ubiquitination and subsequent degradation of p85 subunit of PI-3' kinase . Likewise, the long splice form of Cbl-3 facilitates ubiquitination of EGF receptor (Levkowitz et al., 1999) .
Taken together, these studies indicate that Cbl proteins, acting as E3 ubiquitin-protein ligases, employ widely varying modes of binding for dierent protein targets. It has been shown that c-Cbl binds the receptors for EGF and PDGF, through its TKB domain (Bonita et al., 1997; Levkowitz et al., 1999; Thien and Langdon, 1997) to Fyn primarily through its proline-rich domain and to the insulin receptor through a speci®c adapter protein (Ahmed et al., 2000) . Furthermore, although the role of c-Cbl TKB in its binding to Syk, as well as Zap, has been well documented (Deckert et al., 1998a; Lupher et al., 1996 , in some systems, in which c-Cblmediated inhibition of Syk occurs, Syk binds to c-Cbl via the C-terminal domain of the latter Ota and Samelson, 1997) . Consistent with these results, DNA synthesis stimulated in ®broblasts by a constitutively active form of Src is eectively inhibited by c-Cbl with a de®cient SH2-like domain, but not by c-Cbl lacking its C-terminal domain containing prolinerich motifs and major tyrosine phosphorylation sites (Broome et al., 1999) .
Ubiquitination of EGF receptor by Cbl-b is mediated by its TKB domain (Levkowitz et al., 1999) . In contrast, Cbl-b-induced ubiquitination of p85 is mediated by the interactions of proline-rich motifs of Cbl-b with the SH3 domain of p85 . Cbl-3 binds to EGF receptor and a restricted set of SH3-containing proteins, including Fyn, through its TKB domain and proline-rich motifs, respectively (Keane et al., 1999; Kim et al., 1999; Levkowitz et al., 1999) .
Ubiquitination-mediated downregulation of PTKs is not a speci®c feature of mammalian Cbl proteins only, but appears to be a common function of all vertebrate and invertebrate Cbl proteins. In fact, initial indications that Cbl proteins negatively regulate receptor PTKs came from genetic studies in Caenorhabditis elegans. It was found that loss-of-function mutations in Sli-1, a C. elegans Cbl homolog, restored signaling mediated by Let-23, a C. elegans homolog of EGF receptor, whereas increasing the copy number of sli-1 gene suppressed this signaling Yoon et al., 1995) . Similarly, studies in Drosophila indicate that D-Cbl proteins negatively regulate EGF receptor-mediated signaling involved in the development of photoreceptor cells and dorsoventral patterning (Meisner et al., 1997; Pai et al., 2000) . Furthermore, the results of genetic studies in Drosophila are consistent with the E3 function of Drosophila Cbl proteins (Robertson et al., 2000) .
Although E2-dependent ubiquitination of proteins, which targets them to degradation, is evidently a common function of all Cbl proteins, the biological signi®cance of their ubiquitin-protein ligase activity requires further elucidation. Since major ubiquitination targets for Cbl proteins appear to be PTKs, especially receptor PTKs, general downregulation of PTKdependent responses is likely to be the main biological consequence of Cbl-mediated ubiquitination. However, this outcome is not apparent in all systems where Cbl proteins negatively regulate EGF and PDGF receptor activity. For example, c-Cbl clearly downregulates expression of EGF and PDGF receptors in ®broblasts, but reduces proliferation in some of these systems (Broome et al., 1999; Miyake et al., 1999) , while not in the others (Bonita et al., 1997; Ojaniemi et al., 1997) . Furthermore, a general question of the biological signi®cance of Cbl-mediated downregulation of PTK activity remains to be addressed. It may be speculated that, by targeting pools of activated PTK molecules to ubiquitin-dependent degradation, Cbl proteins can provide a negative feedback mechanism that returns PTKs from their state of transient, ligand-induced activation to their basal activity corresponding to nonstimulated cells. Considering the synchronicity of time courses for degradation of receptor PTKs and those for disappearance of their tyrosine-phosphorylated forms, this mechanism is likely to play a signi®cant role in deactivating receptor PTKs (Levkowitz et al., 1998 (Levkowitz et al., , 1999 Miyake et al., 1998; Waterman et al., 1999b) . However, a contribution of ubiquitinationdependent degradation to the deactivation of nonreceptor PTKs is less clear, since dephosphorylation of transiently activated non-receptor PTKs appears to be signi®cantly more rapid than their c-Cbl-mediated degradation. For example, the half-life of hyperactivated Fyn co-expressed with c-Cbl in COS cells is approximately 3 h , whereas Fyn activity in T cells returns to its basal level within 1 h after TCR/CD3 crosslinking (Burkhardt et al., 1994; Dasilva et al., 1992; Tsygankov et al., 1992) .
A very plausible biological function of Cbl-mediated ubiquitination with regard to its eect on PTK activity is negative regulation of constitutively activated PTKs, for example, deregulated oncogenic receptor PTKs. This possibility is supported by the ®nding that c-Cbl suppresses growth of Neu-transformed neuroblastoma in mice (Levkowitz et al., 2000) . This eect of c-Cbl on tumor growth in vivo appears to be a consequence of the c-Cbl-mediated ubiquitination-dependent removal of oncogenic Neu from the cell surface (Levkowitz et al., 2000) . Consistent with these ®ndings, c-Cbl has been implicated in degradation of HER-2/ErbB-2, the human form of Neu that promotes metastatic breast cancer, by its ligation with anti-HER-2/ErbB-2 or EGF. It has been shown that this degradation is preceded by ubiquitination of HER-2/ErbB-2, which depends on its binding to c-Cbl . Therefore, the therapeutic potential of HER-2/ErbB-2-speci®c antibodies against breast cancer may be due to their ability to cause c-Cbl-mediated degradation of HER-2/ErbB-2.
c-Cbl-dependent downregulation of PTKs, especially receptor PTKs, raises a question of its own regulation. A recent study, focusing on the interactions of human c-Cbl and short Drosophila Cbl (D-Cbl) with human and Drosophila Sprouty proteins, indicates that Sprouty, which binds to the RING ®nger of Cbl proteins, inhibits c-Cbl-mediated downregulation of EGF receptor, most likely, through the competition with E2 ligases for the RING ®nger (Wong et al., 2001) .
Ubiquitination-independent inhibition of tyrosine phosphorylation by Cbl proteins
Although Cbl proteins clearly function as E3 ubiquitinprotein ligases, it remains uncertain whether or not PTK inhibition by Cbl proteins is always dependent on ubiquitination. For example, in spite of a dramatic increase in Zap activity in T cells from c-Cbl-de®cient mice or in a c-Cbl-de®cient B-cell line, no increase in protein levels of these PTKs has been detected in these cells (Murphy et al., 1998; Naramura et al., 1998; Thien et al., 1999) . Furthermore, kinase activity of cSrc is inhibited by binding of phosphotyrosine 416 of c-Src to c-Cbl TKB in HEK293 cells expressing a v b 3 vitronectin receptor (Sanjay et al., 2001) . Whereas this inhibition requires the intact c-Cbl SH2-like domain, it is neither RING ®nger-dependent nor accompanied by c-Src degradation (Sanjay et al., 2001) . Consistent with these ®ndings, c-Cbl lacking its RING ®nger inhibits DNA synthesis induced in ®broblasts by Y527F Src, a constitutively active form of this PTK (Broome et al., 1999 ). An additional argument in favor of the existence of ubiquitination-independent mechanisms of Cblmediated PTK inhibition is provided by a study demonstrating that the RING ®nger domain of Sli-1 is partially dispensable for negative regulation of C. elegans development by this Cbl homolog (Yoon et al., 2000) .
Furthermore, it is feasible that c-Cbl inhibits tyrosine phosphorylation-induced signaling without inhibiting PTK activity per se. For example, c-Cblinduced speci®c inhibition of tyrosine phosphorylation of PLC-g2 and overall PLC-g2-dependent signaling in DT40 B cells appears to be caused by the TKBdependent binding of c-Cbl to the adapter protein BLNK that disrupts the interaction between BLNK and PLC-g2 required for hyperphosphorylation of the latter (Yasuda et al., 2000) .
Transformation by c-Cbl mutants and its connection to ubiquitination
The ability of wild-type Cbl proteins to downregulate PTKs underlies the molecular mechanism by which some of their mutant forms cause cell transformation. As discussed above, c-Cbl was initially identi®ed as a cellular form of the transforming v-Cbl protein, which is formed by a vast C-terminal truncation and consists of the TKB domain only (Blake et al., 1991) . Another oncogenic form of c-Cbl, termed 70Z-Cbl, exhibits a 17-amino acid deletion that removes C381, the ®rst cysteine residue of the RING ®nger, and most of the linker domain between TKB and the RING ®nger (Andoniou et al., 1994; Blake et al., 1991; Zheng et al., 2000) . Consistent with the loss of E3 activity by the oncogenic c-Cbl mutants, it is has been concluded that they act as dominant-negative proteins competing with wild-type c-Cbl for tyrosine-phosphorylated PTKs and, hence, abrogating the negative-regulatory eect of cCbl. Indeed, v-Cbl loses its transformation potential as a result of G306E mutation, which disrupts the ability of TKB to bind to activated PTKs (Bonita et al., 1997; Thien and Langdon, 1997) . This model is also supported by the ®ndings indicating that 70Z-Cbl, which is capable of activating NF-AT and AP-1 transcription factors, loses this ability as a result of G306E mutation (Graham et al., 2000; Liu et al., 1997a; Rao et al., 2000; van Leeuwen et al., 1999a,b; Zhang et al., 1999a) .
However, it remains to be elucidated whether this model presents a complete explanation of the oncogenic eects of Cbl mutants. Extensive mutational analysis of c-Cbl has indicated that a loss of ability to ubiquitinate PTKs does not necessarily lead to oncogenicity, although the known transforming mutants of c-Cbl lack the ability to promote ubiquitination (Thien et al., 2001) . Instead, oncogenic mutations appear to be located in the region linking the TKB domain and the RING ®nger (Thien et al., 2001) . Based on the crystal structure of c-Cbl/UbcH7/ phospho-Zap peptide complex, the linker interacts with both UbcH7 and the TKB domain of c-Cbl (Zheng et al., 2000) , and, therefore, its mutations may disrupt both E2-dependent activity and PTK-binding ability of c-Cbl. These ®ndings raise the possibility that Cbl transformation is dependent on eects additional to ubiquitination of PTKs. This possibility is supported by the ®ndings arguing that c-Cbl may inhibit PTKs in a manner independent of the ubiquitination-mediated mechanism (see above).
Dierential functions of mammalian CBL-family members
In apparent contrast to the expression of Cbl proteins in invertebrate species, multiple members of the Cbl family are present in mammals. (The presence of several Cbl proteins in other vertebrates is possible, but has not been proven yet.) This peculiarity of mammalian species raises an intriguing question of dierential functions of Cbl-family proteins. Although ubiquitination-mediated downregulation of PTKs appears to be a common activity of all Cbl proteins, including members of the mammalian Cbl family, multiple ®ndings point out signi®cant functional dierences between c-Cbl, Cbl-b and Cbl-3.
Thus, c-Cbl has been shown to inhibit the activity of Zap (Murphy et al., 1998; Naramura et al., 1998; Thien et al., 1999; Zhang et al., 1999b) and of AP-1 and NF-AT transcription factors (Rellahan et al., 1997; van Leeuwen et al., 1999a; Yankee et al., 1999) . In contrast, Cbl-b has been shown to facilitate activation of NF-AT in a Zap-dependent manner (Zhang et al., 1999b) . Furthermore, Cbl-b exhibits the ability to inhibit Vav-mediated signaling leading to the activation of Jnk (Bustelo et al., 1997) . Considering that Vavmediated signaling plays a major role in CD28 costimulation (Hehner et al., 2000; Michel et al., 1998 Michel et al., , 2000 Salojin et al., 1999) , these cell signaling-related ®ndings may explain dierences in biological eects of c-Cbl and Cbl-b.
Studies utilizing c-Cbl-de®cient mice show that TCR/ CD3-induced tyrosine phosphorylation and activity of Zap, as well as tyrosine phosphorylation of Slp-76 and Lat, are increased in c-Cbl-negative thymocytes (Murphy et al., 1998; Naramura et al., 1998; Thien et al., 1999) , as is the activation of PI-3' kinase and Erk (Naramura et al., 1998) . Furthermore, TCR/CD3-induced proliferation of c-Cbl-de®cient thymocytes is increased (Murphy et al., 1998) . Consistent with these changes, lymphoid hyperplasia has been reported in cCbl-de®cient mice (Murphy et al., 1998) . In contrast, Cbl-b-negative peripheral T cells demonstrate no increase in tyrosine phosphorylation of Zap or other proteins or in Erk activation in response to TCR/CD3 ligation Chiang et al., 2000) . However, they show a dramatic increase in IL-2 production and proliferation, which is especially evident for TCR/CD3 stimulation in the absence of CD28 co-stimulation Chiang et al., 2000) . Furthermore, the lack of Cbl-b can restore normal responses to stimulation in CD28-de®cient T cells Chiang et al., 2000) . Therefore, Cbl-b de®ciency renders T cells less dependent on CD28 co-stimulation, thus reducing their triggering threshold. Consistent with these ®ndings, Cbl-b-de®cient mice exhibit numerous signs of generalized autoimmune disorder Chiang et al., 2000) . Finally, in agreement with the notion that Vav signaling is a major contributor to CD28 co-stimulation, a loss of Cbl-b restores proliferation and cytotoxicity of Vav-de®cient T cells and promotes spontaneous autoimmunity in Vav-de®cient mice .
Another important dierence between c-Cbl-and Cbl-b-negative mice is apparent in the thymic development. Whereas positive selection of thymocytes expressing class II MHC-restricted TCR is enhanced in c-Cbl-de®cient mice (Naramura et al., 1998) , no changes in the thymic development have been observed in Cbl-b-negative mice Chiang et al., 2000) . However, these dierences may be explained by the dierential expression of c-Cbl and Cbl-b in thymocytes and mature T cells, which appears to be likely, since: (a) the level of c-Cbl protein in mature T cells is less than 5% of that in thymocytes (Naramura et al., 1998) ; (b) c-Cbl mRNA level in thymus is higher than that in spleen (Langdon et al., 1989b) , whereas Cbl-b mRNA level is higher in spleen than in thymus (Bustelo et al., 1997) ; and (c) c-Cbl mRNA level is reduced in the course of dierentiation of several cell lines (Mushinski et al., 1994) .
Although no comparable data on the functions of Cbl-3 are available, the biological eect of Cbl-3 is likely to dier substantially from that of c-Cbl and Cbl-b, due to a radical dierence in its expression.
Indeed, hematopoietic cells lack Cbl-3, which is expressed primarily in the digestive tract. Furthermore, Cbl-3 has no extensive C-terminal domain and, therefore, is unlikely to play an adapter role comparable to that of c-Cbl and Cbl-b.
Conclusion: the contribution of adapter functions to the overall biological role of CBL proteins
The analysis of biological activities of Cbl proteins supports the idea that the conserved E3 proteinubiquitin ligase activity of Cbl proteins is their evolutionary primordial function. However, the biological signi®cance of this function remains to be elucidated. It remains unclear whether the sole biological consequence of the Cbl-mediated ubiquitination is negative regulation of activated PTKs or other crucial proteins can also be degraded in a Cbldependent manner. Nor is it clear whether degradation of PTKs is the only mechanism mediating their negative regulation by Cbl proteins, since several studies strongly argue that inhibition of PTKs by Cbl proteins may occur in a ubiquitination-independent manner.
Furthermore, multiple lines of experimentation indicate that many eects of Cbl proteins are unrelated to their E3 activity, but are related instead to their ability to interact with other proteins critically involved in signal transduction. This aspect of biological activity of Cbl proteins, which can be best de®ned as the adapter function, is most evident for c-Cbl. Multiple studies demonstrate that c-Cbl and, to some extent, Cbl-b exert many of their biological eects by recruiting various proteins to physiologically relevant complexes, thus mediating transduction of cellular signals. Signaling that is apparently dependent on the adapter function of Cbl proteins has been implicated in cell proliferation, survival, adhesion, morphology, and migration, as well as in the developing of anergy in T lymphocytes. The adapter functions of c-Cbl and, possibly, other Cbl proteins appear to be mediated primarily by the C-terminal domain containing multiple proline-rich motifs and tyrosine phosphorylation sites. Recent ®ndings clearly demonstrate that the cCbl C-terminal domain, including all its major tyrosine phosphorylation sites and proline-rich motifs, is highly conserved in vertebrates (see Figure 1) , strongly supporting the notion of the importance of adapter functions for the overall biological activity of c-Cbl. At present, less is known about the mechanisms underlying the biological role of Cbl-b, another mammalian Cbl protein with an extensive C-terminal domain, and very little can be said about D-CblL, a form of Drosophila Cbl with a long C-terminal domain. However, it is possible that these proteins, especially Cbl-b, are also capable of acting as multivalent molecular adapters.
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